Differential Expression of Myc Family Genes During Murine Development
Authors
Affiliations
The myc family of cellular oncogenes contains three known members. The N-myc and c-myc genes have 5'-noncoding exons, strikingly homologous coding regions, and display similar oncogenic potential in an in vitro transformation assay. The L-myc gene is less well characterized, but shows homology to N-myc and c-myc (ref. 6; also see below). c-myc is expressed in most dividing cells, and deregulated expression of this gene has been implicated in the development of many classes of tumours. In contrast, expression of N-myc has been found only in a restricted set of tumours, most of which show neural characteristics; these include human neuroblastoma, retinoblastoma and small cell lung carcinoma (SCLC). L-myc expression has so far been found only in SCLC. Activated N-myc and L-myc expression has been implicated in oncogenesis; for example, although N-myc expression has been found in all neuroblastomas tested, activated (greatly increased) N-myc expression, resulting from gene amplification, is correlated with progression of the tumour. We now report that high-level expression of N- and L-myc is very restricted with respect to tissue and stage in the developing mouse, while that of c-myc is more generalized. Furthermore, we demonstrate that N-myc is not simply a neuroectoderm-specific gene; both N- and L-myc seem to be involved in the early stages of multiple differentiation pathways. Our findings suggest that differential myc gene expression has a role in mammalian development and that the normal expression patterns of these genes generally predict the types of tumours in which they are expressed or activated.
MYC in cancer: from undruggable target to clinical trials.
Whitfield J, Soucek L Nat Rev Drug Discov. 2025; .
PMID: 39972241 DOI: 10.1038/s41573-025-01143-2.
Jung E, Raduski A, Mills L, Spector L HGG Adv. 2024; 6(1):100356.
PMID: 39340156 PMC: 11538869. DOI: 10.1016/j.xhgg.2024.100356.
Ibarra-Garcia-Padilla R, Nambiar A, Hamre T, Singleton E, Uribe R PLoS One. 2024; 19(9):e0310727.
PMID: 39292691 PMC: 11410271. DOI: 10.1371/journal.pone.0310727.
Acosta-Plasencia M, Castellano J, Diaz T, He Y, Marrades R, Navarro A Stem Cell Res Ther. 2024; 15(1):263.
PMID: 39183355 PMC: 11346212. DOI: 10.1186/s13287-024-03883-1.
Immune evasion: An imperative and consequence of MYC deregulation.
Krenz B, Lee J, Kannan T, Eilers M Mol Oncol. 2024; 18(10):2338-2355.
PMID: 38957016 PMC: 11459038. DOI: 10.1002/1878-0261.13695.